Strict diet explains metabolic effect of gastric bypass surgery

August 13, 2020

In many studies, bariatric surgery has been highlighted as an almost magical method for weight loss and reversing type 2 diabetes. One question that has remained largely unanswered is how the effect of surgery differs from the effects of a strict low-calorie diet. This question has now been examined by researchers at Lund University in Sweden in a study published in the journal Diabetes.

By monitoring individuals who underwent a six-week low-calorie diet followed by a bariatric operation, they can for the first time show why several health markers improve.

"What we previously thought was an effect of the operation is actually due to the diet", says associate professor Nils Wierup, who led the study with associate professor Peter Spégel.

In a bariatric operation, a so-called gastric bypass, a large part of the stomach and the first part of the small intestine are disconnected. The patient needs to lose weight before the operation in order to reduce the size of the liver and the amount of fat around the internal organs. This is done to reduce the risk of complications.

Normally, the patient follows a strict six-week diet of fewer than 1 000 calories per day in order to achieve the weight loss. Previous research has studied the combined effect of the diet and surgery. What has been seen, in addition to weight loss, is improved blood sugar control, which has been considered a result of an increase in the hormones GLP-1 and GIP and enhanced insulin release. As a bonus, individuals with type 2 diabetes "recovered" just days after the procedure.

In a new study, researchers at the Lund University Diabetes Centre (LUDC) and the Centre for Analysis and Synthesis (CAS) have for the first time studied the effects of the strict low-calorie diet and the operation separately. The results show that the diet alone accounted for the greatest positive effect.

"More than 90 per cent of everything that occurred, happened as a result of the diet. Very little changed after the surgery", says Peter Spégel, who works at LUDC and CAS.

By measuring several hundred metabolites in the blood (substances formed by, among other things, sugar, protein and fat in our metabolism) before and after the low calorie diet and the operation, the researchers could see that the levels of the various metabolites after the diet went in the direction expected from a reduced food intake and improved health. The surgery itself caused very minor changes.

However, a few unique changes were observed that generally were the opposite of those that happened during the diet. The researchers could link some of these effects to the stress that surgery causes for the patient, and this was supported by the fact that virtually all the changes had disappeared six weeks after the operation.

The one most surprised by the results is Nils Wierup, who previously, unlike Peter Spégel, was convinced that it was the surgical procedure and the hormonal changes that accounted for the improved effect.

"What we previously thought was linked to the gastric bypass surgery is actually not. I have had to change my viewpoint", he says.

"It was very good for this project that at the start we had such differing expectations and hypotheses on the effects bariatric surgery and diet have on metabolism. We have therefore looked very carefully at all the results to elucidate the study from all conceivable angles", adds Peter Spégel.

The results are not to be interpreted as the low-calorie diet being beneficial in itself or that the operation is unnecessary. The procedure is necessary in order for the patient to maintain a limited food intake for a long period.

"A low-calorie diet is usually not harmful. The fact that we have now shown the effects previously associated with surgery actually arise during the preceding low-calorie diet, and not as a response to the surgery, may perhaps make gastric bypass surgery less magical.

However, as a result of this, we can also point to bariatric surgery not having any negative metabolic consequences", says Peter Spégel.

"If you are seriously overweight, calorie restriction is not necessarily harmful. Gastric bypass is a good treatment method for obesity. In addition to the weight loss being more considerable and long-lasting compared to a low-calorie diet, the surgery has the added effect that the patient's diabetes reverses", states Nils Wierup.

The results also raise new questions.

"If metabolism is primarily affected by the diet and not the surgery, what then is the function of the hormones GLP-1 and GIP?", says Nils Wierup.

The answers will possibly emerge from forthcoming studies in which the researchers will conduct a long-term follow up and compare their results in a European study.
The study is published in the journal Diabetes.

About the study:

The study involved 19 women with a body mass index (BMI) of over 35. Nine had type 2 diabetes from the start and ten had a normal blood sugar level. During the six weeks before the operation, the participants followed a low-calorie diet with an aim to lose five per cent of their body weight. The participants submitted blood samples before and after the diet and operation, and underwent a so-called post-prandial test, in which the body's response to a standard meal is measured. In this study, they have measured changes in the level of 176 known and 719 unknown metabolites, substances in our metabolism formed when the body metabolises food.

The operations were performed at the County Hospital in Kalmar by Johan Berggren, doctoral student and gastric bypass surgeon. Katarina Herzog, postdoc, is responsible for analysis of samples and subsequent analysis of data. The study design was planned in cooperation with associate professor and consultant Jan Hedenbro.

Lund University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to